Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review

Oncotarget
Anjali V SheahanLevon M Khachigian

Abstract

Pancreatic cancer has a dismal prognosis particularly in patients presenting with unresectable tumors. We performed a bibliometric analysis of clinical trials for pancreatic cancer conducted between 2014-2016 focusing on patients that presented with unresectable (locally advanced or metastatic) tumors. We discuss a range of studies that employed FOLFIRINOX, the gemcitabine + nab-paclitaxel combination and studies that used molecularly-targeted therapy. Major areas of focus have been dual targeting of EGFR and VEGFR, immunotherapy or a multimodal approach - combining chemotherapy with radiotherapy. We also point out the need for molecular selection for low prevalence subtypes. Key insights sourced from these pivotal trials should improve clinical outcomes for this devastating cancer.

References

Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Mar 23, 2013·Current Cancer Drug Targets·Anjali V SheahanLevon M Khachigian
Aug 21, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William A HoosLynn M Matrisian
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Feb 27, 2014·British Journal of Cancer·M T HuggettS P Pereira
Mar 13, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D J WatkinsI Chau
Apr 15, 2014·International Journal of Radiation Oncology, Biology, Physics·E Gabriela ChioreanHiginia R Cardenes
Jun 12, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jeffrey R InfanteNgocdiep Le
Jul 25, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shigeo KoidoHisao Tajiri
Oct 4, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edward J KimDiane M Simeone
Dec 17, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitesh J BoradDavid P Ryan
Jan 8, 2015·Annals of Surgical Oncology·Shalini MoningiJoseph M Herman
Jan 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dung T LeElizabeth M Jaffee
Apr 10, 2015·Nature Communications·Agnieszka K WitkiewiczErik S Knudsen
Apr 22, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lorraine A ChantrillUNKNOWN Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial Management Committee of the Australasian Gastrointestinal
Jun 10, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Annette A van ZweedenHenk M W Verheul
Aug 8, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew H KoW Michael Korn
Sep 24, 2015·Oncotarget·Luca FaloppiUNKNOWN Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Oct 29, 2015·Cancer Chemotherapy and Pharmacology·Zheng WuAiwu Ruth He
Nov 4, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel V T CatenacciHedy L Kindler
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 13, 2016·International Journal of Radiation Oncology, Biology, Physics·Aaron T WildSusannah G Ellsworth

❮ Previous
Next ❯

Citations

Nov 16, 2018·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Paola SaccomandiGiuseppe Quero
Jan 13, 2019·Targeted Oncology·Zhuanglin LiChangjiang Huang
Mar 20, 2019·Scientific Reports·Byunghee YooZdravka Medarova
Apr 2, 2019·Clinical and Translational Medicine·S K DanielV G Pillarisetty
Jan 7, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Nikola Ž KneŽevićJean-Olivier Durand
Nov 6, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Bin Wu, Lizheng Shi
Jul 6, 2019·Cancer Research·Aditi JainJonathan R Brody
Jan 23, 2021·RSC Medicinal Chemistry·Jufeng SunAdam McCluskey
Feb 2, 2020·Biochemical and Biophysical Research Communications·Satoko UemuraShinya Tanaka
Mar 27, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Namdev DhasTejal Mehta
Jan 21, 2019·Gastroenterology·Laura D WoodMichael G Goggins
Apr 4, 2021·Cancer Treatment Reviews·Sara De DossoMarkus Borner
Nov 13, 2020·Visceral Medicine·Katrin Jana CiecielskiHana Algül

❮ Previous
Next ❯

Software Mentioned

GLOBOCAN
MPACT
PRODIGE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen
O Strobel, M W Büchler
Nihon rinsho. Japanese journal of clinical medicine
Satoshi Shimizu
The New England Journal of Medicine
Vanja VaccaroMichele Milella
Expert Review of Gastroenterology & Hepatology
Lei ZhangDaiming Fan
© 2022 Meta ULC. All rights reserved